CG
TSVT

Colony Group’s 2seventy bio TSVT Stock Holding History

Colony Group’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$209K Buy
53,275
+2,645
+5% +$17.3K ﹤0.01% 721
2023
Q2 		$512K Buy
50,630
+29,428
+139% +$312K 0.01% 559
2023
Q1 		$216K Sell
21,202
-2,094
-9% -$23.9K ﹤0.01% 737
2022
Q4 		$218K Buy
23,296
+8,968
+63% +$126K ﹤0.01% 780
2022
Q3 		$208K Buy
14,328
+318
+2% +$4.72K ﹤0.01% 734
2022
Q2 		$185K Buy
+14,010
New +$191K ﹤0.01% 786

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Colony Group's TSVT Position: Q3 2023 in Review

Colony Group increased its 2seventy bio (TSVT) stake by 5.2% in Q3 2023, buying an estimated $17.3K and bringing the position to 53,275 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #721.

Colony Group first reported a position in TSVT in Q2 2022 and has held it in 6 quarters since. The position peaked at $512K in Q2 2023. 145 funds tracked by Wall St. Rank hold TSVT as of Q3 2023.

  • Colony Group held 53,275 shares of 2seventy bio worth $209K as of Q3 2023.
  • Colony Group bought 2,645 2seventy bio shares in Q3 2023, an estimated $17.3K.
  • 2seventy bio made up ﹤0.01% of Colony Group's portfolio in Q3 2023, its #721 holding.
  • Colony Group first reported a position in 2seventy bio in Q2 2022 and has held it in 6 quarters since.
  • Colony Group's 2seventy bio position peaked at $512K in Q2 2023.
  • 145 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.